Jan‐Willem Koten

Therapeutic efficacy of IL‐2‐loaded hydrogels in a mouse tumor model

Cornelis J. De Groot, J.A. Cadée, Jan‐Willem Koten et al. · International Journal of Cancer · 2001 · 35 citations

The mechanism of regression of solid SL2 lymphosarcoma after local IL-2 therapy

Anton Baselmans, Jan‐Willem Koten, Jan J. Battermann et al. · Cancer Immunology Immunotherapy · 2002 · 22 citations · Full text

Medicine, Immunology, Solid Sl2 Lymphosarcoma +5

Intratumoural interleukin-2 therapy can induce regression of non-resectable mastocytoma in dogs.

Paul G. P. M. Ziekman, Willem Den Otter, J Tan et al. · PubMed · 2013 · 22 citations

Further development of local IL-2 therapy of cancer: multiple versus single IL-2 treatment of transplanted murine colon carcinoma

H Kuśnierczyk, Elżbieta Pajtasz‐Piasecka, Jan‐Willem Koten et al. · Cancer Immunology Immunotherapy · 2004 · 21 citations · Full text

Cancer Immunosurveillance, Local Il-2 Therapy, Gastrointestinal Oncology +11

Therapeutic effect of a single peritumoural dose of IL-2 on transplanted murine breast cancer

I. A. Merkulova, Caspaar Bijleveld, Jan‐Willem Koten et al. · Cancer Immunology Immunotherapy · 2003 · 12 citations · Full text

Radiation Oncology, Breast Oncology, Transplantation +13